Filippo Petti
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Lung Cancer Treatments and Mutations, Cancer Cells and Metastasis, Cancer, Hypoxia, and Metabolism, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non–Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor Inhibition(2005)672 cited
- → Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non–small-cell lung, pancreatic, colon, and breast tumors(2006)233 cited
- → A systems view of epithelial–mesenchymal transition signaling states(2010)211 cited
- → Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions(2008)199 cited
- → Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy(2008)191 cited
- → Phosphotyrosine Signaling Networks in Epidermal Growth Factor Receptor Overexpressing Squamous Carcinoma Cells(2005)134 cited
- → Temporal quantitation of mutant Kit tyrosine kinase signaling attenuated by a novel thiophene kinase inhibitor OSI-930(2005)45 cited
- → Peptide, domain, and DNA affinity selection in the identification and quantitation of proteins from complex biological samples(2006)3 cited
- Proteomic and IHC measurements of cellular sensitivity to EGF receptor kinase inhibitors(2006)